Prolonged overall survival in metastatic gastric cancer treated with ipilimumab and lapatinib

Yanfang Ju1, Shengjie Sun1, Shunchang Jiao1

  • 1Department of Oncology, Chinese PLA General Hospital, Beijing, China.

Abstract

Insights

Combination therapy using targeted drugs like lapatinib and immunotherapy (ipilimumab) showed promising results for a patient with metastatic gastric cancer, extending survival by four years.

Area of Science:

  • Oncology
  • Immunotherapy
  • Gastrointestinal Oncology

Background:

  • Gastric cancer is a leading cause of cancer death globally, with poor prognosis for unresectable or metastatic disease.
  • Targeted therapies (e.g., lapatinib) and immunotherapies represent novel treatment avenues.
  • Investigating innovative therapeutic strategies is crucial for improving patient outcomes.

Observation:

  • A patient with metastatic gastric cancer progressed on trastuzumab therapy.
  • The patient received combination therapy with lapatinib and ipilimumab.
  • Treatment led to prolonged overall survival and positive diagnostic imaging results.

Findings:

  • Positron emission tomography-computed tomography (PET-CT) revealed reduced size and glucose metabolism in metastatic lymph nodes.
  • Tumor marker levels (carcinoembryonic antigen) decreased following treatment.
  • The patient achieved a four-year survival period after initial diagnosis of multiple lymph node metastasis.

Implications:

  • Combination therapy of targeted agents and immunotherapy may offer a viable treatment option for metastatic gastric cancer.
  • This approach could potentially improve survival rates in patients with advanced disease.
  • Further clinical investigation is warranted to validate these findings in a broader patient population.

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
764
Gastric Motility01:16

Gastric Motility

Gastric motility is the coordinated contraction and relaxation of stomach muscles that convert ingested food into chyme, a semi-liquid substance ready for further digestion in the intestines. The process begins with the vagus nerve inducing the relaxation of the smooth muscles in the fundus and body of the stomach, allowing these regions to expand and accommodate up to approximately 1.5 liters of food and liquid.
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
3.2K
Survival Curves01:18

Survival Curves

Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
714
Survival Tree01:19

Survival Tree

Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
429
Gastric Emptying01:16

Gastric Emptying

Gastric emptying occurs when the stomach gradually releases chyme into the duodenum. When the stomach is distended, it triggers the release of gastrin, a hormone that promotes gastric acid secretion to aid in digestion. Additionally, stomach distension contributes to peristaltic waves that propel gastric contents toward the pyloric region. The gastroenteric reflex, on the other hand, primarily stimulates peristalsis in the intestines, facilitating the movement of contents further along the...
3.7K
Gastric Phase of Digestion01:26

Gastric Phase of Digestion

The gastric phase of digestion begins as soon as food enters the stomach. The incoming food bolus triggers neural and hormonal mechanisms, which last approximately 3 to 4 hours. During this phase, the stomach undergoes significant changes to prepare the food for further digestion and absorption.
When food enters the stomach, it stretches the stomach walls and activates stretch receptors. This triggers local reflexes of the enteric nervous system, mediated through the myenteric plexus. These...
3.4K